(-)-Carnitine → HCID 74787530, 화합물

HRID 1599521

반응식

HRID 1599521 반응식
[OH:1][C@H:2]([CH2:8][C:9](=[O:11])[O-:10])[CH2:3][N+:4]([CH3:7])([CH3:6])[CH3:5].[C:12]([Cl:31])(=[O:30])[CH2:13][CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][CH2:19]/[CH:20]=[CH:21]\[CH2:22]/[CH:23]=[CH:24]\[CH2:25][CH2:26][CH2:27][CH2:28][CH3:29]>>[Cl-:31].[C:9]([CH2:8][C@@H:2]([O:1][C:12](=[O:30])[CH2:13][CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][CH2:19]/[CH:20]=[CH:21]\[CH2:22]/[CH:23]=[CH:24]\[CH2:25][CH2:26][CH2:27][CH2:28][CH3:29])[CH2:3][N+:4]([CH3:7])([CH3:5])[CH3:6])([OH:10])=[O:11]

참가 물질

3

반응물 2

HCID 10917(-)-CarnitineHCID 9817754Linoleoyl chloride

생성물 1

HCID 74787530HCID 74787530, 화합물

실험 절차

By processing L-carnitine and linoleoyl chloride in the same manner as described in Reference example 15, (R)-(3-carboxy-2-linoleoyloxypropyl)trimethylammonium chloride was obtained.

출처 및 근거

ORD 기록
ord-0dac294ac1c746d2bf24a35d61124737
출처 데이터셋
uspto-grants-1998_04
특허 번호
US05741816

연결된 노트

불러오는 중…